Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

January 26, 2006Posted inDrug Safety Studies, Safety of hormonal contraceptives, Select Publications
Journal: Contraception Authors: Susan S Jick, James A Kaye, Stefan Russmann, Hershel Jick NLM Citation: Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive…